Add to watch list
Prev Close
0.2500
Today's Open
0.2200
Day's Range
0.2130-0.2500
Volume
420,686
Dollar Volume
$17582.74
Avg Vol(5-day)
30,792
Avg Vol(1-month)
96,748
GT Biopharma Inc Logo

https://www.gtbiopharma.com/

Description

GT Biopharma Inc is an immuno-oncology company operating in the US. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. The key drug candidates of the company are OXS-2175, which is a small molecule therapeutic candidate targeting the treatment of triple-negative breast cancer; OXS-4235, which is a small molecule therapeutic candidate, targets the treatment of multiple myeloma and associated osteolytic lesions; and OXS-1550, which targets cancer cells expressing the CD19 receptor and CD22 receptor.

Company Address

CEO: Shawn Cross
100 SOUTH ASHLEY STREET SUITE 600
TAMPA, FL 33602
United States
We don't have any subsidiaries for GT Biopharma Inc.

Have a suggestion?

Please Contact Us to let us know.